Observational study of pancreatic cancer in Copenhagen
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study is observing people with pancreatic cancer in Copenhagen to learn more about the disease. It is open to anyone with a confirmed diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with pancreatic cancer confirmed by a biopsy or tissue sample.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at “biomarkers” (test signals in tissue or blood) in people with pancreatic cancer. It may help researchers understand the disease better and find ways to predict or track it.
This study collects health information and stored samples (biospecimens) to learn more about pancreatic diseases, including cancer and early warning changes. It may help researchers understand who is at higher risk and improve future testing and care.
This study collects information from people diagnosed with pancreatic cancer. It aims to improve care by learning from your medical records.
This study looks at factors in the family and the environment that may be linked to pancreatic cancer. It includes people with pancreatic cancer and several types of pancreas-related conditions, as well as some healthy volunteers, and may help researchers understand who is at higher risk.
This study collects medical and lab information from adults with pancreatic cancer to help researchers understand care and outcomes. You may be asked for follow-up visits and basic data, and it may be used to improve future treatments.
This trial studies metastatic pancreatic cancer by taking a small tissue sample and analyzing its genes. It may help doctors better understand which cancer subtypes patients have, which can guide future treatment choices.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.